BSH 2019 | Update on CLL research at Memorial Sloan Kettering

Anthony Mato

Anthony Mato, MD, MSCE, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY, discusses the priorities of chronic lymphocytic leykemia (CLL) research at his institute currently. This interview took place at the British Society for Haematology (BSH) 2019 Annual Meeting, held in Glasgow, UK.

Share this video